Skip to content
value.today

CDI Laboratories, Inc.

Formerly Caribbean Dairy Institute, Inc.

Total raised
$3 M
2 rounds on record
Latest round
$2 M
Dec 2020
First round on record
Jun 2015
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of CDI Laboratories, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Dec 2020$2 MNo. 2$2 to $10 million

CDI Laboratories, Inc.: Raise no. 2, Dec 2020

Investors in this round

29 investors had bought by the notice of Jan 15, 2021: 29 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $5 M offered; $3 M still to sell
Smallest investment taken
$25,000
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
$1 million to $5 million
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Puerto Rico

People named in the notice

  • Ignacio Jose Pino Lopez-Castro · Executive Officer, Director
  • Antoine Jose de Marsily · Director
  • Jef Jose Boeke · Director
  • Joseph Jose Bonaventura · Director
  • Paul Jose Horan · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Ignacio Jose Pino Lopez-Castro, President & CEO. Source: SEC Form D, newest notice filed Jan 15, 2021. Read the notice at the SEC.

equitySEC
Jun 2015$1 MNo. 1Under $2 million

CDI Laboratories, Inc.: Raise no. 1, Jun 2015

Investors in this round

14 investors had bought by the notice of Jul 1, 2015: 14 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $3 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
$1 million to $5 million
Sales commissions
$31,997
Finders' fees
none
Paid to its own people
$180,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Puerto Rico

People named in the notice

  • Ignacio Jose Pino Lopez-Castro · Executive Officer, Director
  • Daniel Daniel Eichinger · Director
  • Jef Daniel Boeke · Director
  • Joseph Daniel Bonaventura · Director
  • Paul Daniel Horan · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Fairbridge Capital Markets, Inc. (CRD 103818) · broker-dealer Abdon Gerardo Ruiz dDel Valle (CRD 103818) · Guaynabo, Puerto RicoSold in CA, CT, MD, PR

Signed by Ignacio J. Pino L?pez-Castro, President & CEO. Source: SEC Form D, newest notice filed Jul 1, 2015. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • CDI Laboratories, Inc. had revenue between $1 million and $5 million when it filed its newest notice of a funding round (Jan 2021).

    SEC Form D (revenue range) · Jan 2021

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Jan 2021

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of CDI Laboratories, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 29 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by CDI Laboratories, Inc.
NameRoleNamed in
Ignacio Jose Pino Lopez-CastroExecutive officerJan 2021
Antoine Jose de MarsilyDirectorJan 2021
Ignacio Jose Pino Lopez-CastroDirectorJan 2021
Jef Jose BoekeDirectorJan 2021
Joseph Jose BonaventuraDirectorJan 2021
Paul Jose HoranDirectorJan 2021
Daniel Daniel EichingerDirectorJul 2015
Jef Daniel BoekeDirectorJul 2015
Joseph Daniel BonaventuraDirectorJul 2015
Paul Daniel HoranDirectorJul 2015